Clinical Trials - BDRX

NCT ID	Title	Status	Phases	Start Date	Completion Date	Primary Completion Date
NCT05324501	A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma	TERMINATED	PHASE1	2022-10-19	2024-09-10	2024-09-10